文献速递甲状腺疾病糖尿病

甲状腺功能对代谢功能障碍相关脂肪性肝病患病率及死亡率的影响

Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

基于美国第三次国家健康与营养调查(NHANES III)10666名参与者的数据,探讨甲状腺功能状态对代谢功能障碍相关脂肪性肝病(MAFLD)患病率及死亡率的影响。结果显示,低甲状腺功能与MAFLD独立相关(比值比1.27),亚临床甲状腺功能减退症与全因及心血管死亡率风险升高显著相关,在MAFLD人群中风险更高。作者认为应考虑重新评估促甲状腺激素参考范围。

要点

  • 低甲状腺功能与MAFLD独立相关,比值比为1.27。
  • 亚临床甲状腺功能减退症与总人群及MAFLD人群全因和心血管死亡率升高显著相关。
  • 在甲状腺功能谱中,轻度亚临床甲状腺功能减退症的死亡风险 hazard ratio 最高。

核心结论

  • 低甲状腺功能是MAFLD的独立危险因素,并与MAFLD人群全因及心血管死亡率风险升高相关。
  • 作者认为应考虑重新评估促甲状腺激素参考范围。

研究设计与样本

  • 研究使用美国第三次国家健康与营养调查(NHANES III)中10666名参与者的数据。
  • MAFLD根据新定义诊断。
  • 甲状腺素参考范围内甲状腺功能变异根据促甲状腺激素(TSH)水平定义:亚临床甲状腺功能亢进症<0.39 mIU/L;严格正常甲状腺功能0.39-2.5 mIU/L;低甲状腺功能>2.5 mIU/L,包括低正常甲状腺功能(2.5-4.5 mIU/L)和亚临床甲状腺功能减退症(>4.5 mIU/L)。
  • 多变量分析采用逻辑回归和Cox回归。

主要发现

  • 低甲状腺功能与MAFLD独立相关,比值比为1.27。
  • 与严格正常甲状腺功能相比,亚临床甲状腺功能减退症与总人群全因死亡率风险升高显著相关(风险比1.23),与心血管死亡率风险升高显著相关(风险比1.65)。
  • 与严格正常甲状腺功能相比,亚临床甲状腺功能减退症与MAFLD人群全因死亡率风险升高显著相关(风险比1.32),与心血管死亡率风险升高显著相关(风险比1.99)。
  • 在低正常甲状腺功能组中,观察到死亡风险呈增加趋势。
  • 低甲状腺功能对总人群和MAFLD人群的死亡率均显示显著负面影响。

关键数值与推荐

  • 亚临床甲状腺功能亢进症:TSH <0.39 mIU/L。
  • 严格正常甲状腺功能:TSH 0.39-2.5 mIU/L。
  • 低甲状腺功能:TSH >2.5 mIU/L,包括低正常甲状腺功能(2.5-4.5 mIU/L)和亚临床甲状腺功能减退症(>4.5 mIU/L)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Thyroid function variation within the thyroxine reference range has negative metabolic effects. Metabolic dysfunction-associated fatty liver disease (MAFLD) is a recently proposed definition. OBJECTIVE: We aim to explore the effects of thyroid function status on prevalence and mortality of MAFLD. METHODS: Data of 10 666 participants from the Third National Health and Nutrition Examination Survey (NHANES III) were used. MAFLD was diagnosed based on the new definition. Thyroid function variation within the thyroxine reference range was defined based on thyroid-stimulating hormone (TSH) levels: subclinical hyperthyroidism, <0.39 mIU/L; strict-normal thyroid function, 0.39-2.5 mIU/L; and low thyroid function, >2.5 mIU/L, which comprised low-normal thyroid function (2.5-4.5 mIU/L) and subclinical hypothyroidism (> 4.5 mIU/L). Logistic and Cox regression were used in multivariate analysis. RESULTS: Low thyroid function is independently associated with MAFLD (odds ratio: 1.27). Compared with strict-normal thyroid function, subclinical hypothyroidism was significantly associated with increased risk for all-cause and cardiovascular mortality in the total population (hazard ratio [HR] for all-cause: 1.23; cardiovascular: 1.65) and MAFLD population (HR for all-cause: 1.32; cardiovascular: 1.99); meanwhile, in the low-normal thyroid function group, an increasing trend in mortality risk was observed. Furthermore, low thyroid function also showed significant negative impact on mortality in the total and MAFLD population. Among thyroid function spectrum, mild subclinical hypothyroidism showed the highest HRs on mortality. CONCLUSIONS: Low thyroid function is independent risk factor of MAFLD and is associated with increased risk for all-cause and cardiovascular mortality in the MAFLD population. Reevaluation of TSH reference range should be considered.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chen YL, Tian S, Wu J, et al. Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease. J Clin Endocrinol Metab. 2023. PMID: 36637992. doi:10.1210/clinem/dgad016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。